---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-018566"
form_type: "8-K"
ticker: "WINT"
cik: "0000946486"
company_name: "WINDTREE THERAPEUTICS INC /DE/"
filed_at: "2023-06-27T23:59:59+00:00"
generated_at: "2026-06-13T16:43:53.123214+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Windtree Therapeutics appoints Mark Strobeck to Board and names Craig Fraser as Chair

## Summary
- Appointed Mark Strobeck, Ph.D. to the Board effective June 22, 2023; serves on Audit and Compensation Committees.
- Dr. Strobeck is President & CEO of Rockwell Medical; brings biotech/pharma management and M&A experience.
- Appointed Craig E. Fraser as Board Chair and Leslie J. Williams as Lead Independent Director, effective June 22, 2023.
- Strobeck receives annual cash retainer per non-employee director policy; initial equity grant under evaluation.

## SEC filing metadata
- accession: 0001437749-23-018566
- form_type: 8-K
- ticker: WINT
- cik: 0000946486
- company_name: WINDTREE THERAPEUTICS INC /DE/
- filed_at: 2023-06-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946486/000143774923018566/0001437749-23-018566-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946486/000143774923018566/wint20230626_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-018566
- JSON: https://secwatch.observer/filing/0001437749-23-018566.json
- Plain text: https://secwatch.observer/filing/0001437749-23-018566.txt

## Key facts
- Executive change
  Mark Strobeck was appointed as Director at WINDTREE THERAPEUTICS INC /DE/.
  - Action: appointed
  - Role: Director
  source text: On June 22, 2023, the board of directors (the “ Board ”) of Windtree Therapeutics, Inc. (the “ Company ”) appointed Mark Strobeck, Ph.D., as a member of the Board, effective as of June 22, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/946486/000143774923018566/0001437749-23-018566-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.